| 2024-03-26 | -0.17 % |
|
| 2024-03-25 | -2.67 % |
|
| 2024-03-21 | +4.67 % |
|
| 2024-03-20 | -0.06 % |
|
| 2024-03-19 | +0.91 % |
|
| 2024-03-12 | -2.04 % |
|
| 2024-02-29 | -1.35 % |
- Summary: Bio-Rad Laboratories (BIO) stock was down -1.35% following EVP Michael Crowley's sale of 3,000 shares, and the company has seen fluctuations in its stock price due to factors such as earnings reports, analyst ratings, and investor activities.
Reason for Stock Drop: The stock of Bio-Rad Laboratories (BIO) may have decreased due to EVP Michael Crowley selling 3,000 shares of the company's stock, which could have led to investor concerns or profit-taking resulting in a negative impact on the stock price.
- Summary: Bio-Rad Laboratories (BIO) stock was down 1.35% following its upgrade from a hold to a buy rating by StockNews.com, with previous analyst ratings and the company's financial performance contributing to investor sentiment. The stock sees fluctuations due to various factors such as quarterly earnings results, insider selling activity, and institutional investors' actions.
Reason for BIO stock going down: There are several factors contributing to the stock going down, including a negative net margin of 23.86%, a decrease in revenue, insider selling activities by EVPs Michael Crowley and Dara Wright, and fluctuations caused by institutional investor actions and market sentiment based on various analyst ratings and price targets.
|
| 2024-02-28 | +0.18 % |
|
| 2024-02-27 | -2.49 % |
|
| 2024-02-26 | +0.05 % |
|
| 2024-02-23 | -0.14 % |
|
| 2024-02-22 | -0.05 % |
|
| 2024-02-16 | +3.59 % |
|
| 2024-02-15 | +0.25 % |
|
| 2024-01-26 | +4.03 % |
|
| 2024-01-25 | -0.08 % |
|
| 2024-01-24 | +0.42 % |
|
| 2024-01-22 | +2.03 % |
|
| 2024-01-02 | +1.58 % |
|
| 2023-10-27 | -7.15 % |
|
| 2023-10-26 | +0.5 % |
|
| 2023-10-23 | -2.86 % |
|
| 2023-10-18 | -7.93 % |
|